Feasibility Study of Microbial Ecosystem Therapeutics (MET-4) to Evaluate Effects of Fecal Microbiome in Patients on ImmunOtherapy (MET4-IO)

  • Posted on: 14 August 2018
  • By: admin
Sponsor: 
In-house
NCT#: 
NCT03686202
Eligible Tumour Types: 
Breast Cancer
Colorectal Cancer
Fallopian Tube Tumours
Malignant Pleural Mesothelioma
Metastatic Melanoma
Ovarian Cancer
Solid Cancer
Squamous Cell Cancer of the Head and Neck
Squamous Cell Carcinoma of the Oral Cavity
Triple Negative Breast Cancer
Recruiting Status: 
Recruiting Soon
Principal Investigator: 
Lillian Siu & Anna Spreafico(Second PI)